Genetic Signatures Ltd
ASX:GSS

Watchlist Manager
Genetic Signatures Ltd Logo
Genetic Signatures Ltd
ASX:GSS
Watchlist
Price: 0.4025 AUD 3.21% Market Closed
Market Cap: 91.4m AUD

Wall Street
Price Targets

GSS Price Targets Summary
Genetic Signatures Ltd

Wall Street analysts forecast GSS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GSS is 0.765 AUD with a low forecast of 0.7575 AUD and a high forecast of 0.7875 AUD.

Lowest
Price Target
0.7575 AUD
88% Upside
Average
Price Target
0.765 AUD
90% Upside
Highest
Price Target
0.7875 AUD
96% Upside
Genetic Signatures Ltd Competitors:
Price Targets
CSBR
Champions Oncology Inc
51% Upside
603259
WuXi AppTec Co Ltd
34% Upside
BICO
BICO Group AB
84% Upside
LONN
Lonza Group AG
19% Upside
ADPT
Adaptive Biotechnologies Corp
19% Upside
RGEN
Repligen Corp
57% Upside
BIOT
Biotage AB
2% Upside
DHR
Danaher Corp
27% Upside

Revenue
Forecast

Revenue Estimate
Genetic Signatures Ltd

For the last 8 years the compound annual growth rate for Genetic Signatures Ltd's revenue is 20%. The projected CAGR for the next 3 years is 47%.

20%
Past Growth
47%
Estimated Growth
Estimates Accuracy
3%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Genetic Signatures Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

Net Income
Forecast

Net Income Estimate
Genetic Signatures Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-33%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GSS's stock price target?
Price Target
0.765 AUD

According to Wall Street analysts, the average 1-year price target for GSS is 0.765 AUD with a low forecast of 0.7575 AUD and a high forecast of 0.7875 AUD.

What is Genetic Signatures Ltd's Revenue forecast?
Projected CAGR
47%

For the last 8 years the compound annual growth rate for Genetic Signatures Ltd's revenue is 20%. The projected CAGR for the next 3 years is 47%.

Back to Top